Call for Life: Exploring mHealth Solutions for Enhancing Childhood Vaccinations Among Displaced Children in Conflict-affected Settings of Nigeria (Call 4 Life)

August 26, 2025 updated by: Lundi-Anne Omam Ngo Bibaa, University of Cambridge
This study evaluates the feasibility and preliminary impact of Call for Life, an mHealth platform aimed at increasing childhood vaccination coverage among internally displaced persons in Borno State, Nigeria. The platform uses an interactive voice response (IVR) system to deliver automated vaccination reminders, follow up on reported side effects, and provide health messages in English and local languages. A mixed-methods design is used to assess feasibility, interaction rates, and early effects on vaccine uptake. Findings will inform policymakers and humanitarian actors on the potential of mobile technology to strengthen immunization delivery in conflict-affected, resource-limited settings.

Study Overview

Status

Enrolling by invitation

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

366

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Borno State
      • Jere, Borno State, Nigeria
        • El Miskin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • • Caregivers (male/female) of children from 0-23 months of age or pregnant women in third trimester

    • Caregivers above the age of 18 years of age
    • Caregivers who consent to participate in the study.
    • Resident in the IDP camp for at least one year

Exclusion Criteria:

  • • Pregnant women in third trimester in first pregnancy (primigravida)

    • Caregivers that are temporary residents of the IDP camps (IDPs on transit or visitors)
    • Caregivers without the mental capacity to comprehend the questions asked.
    • Inability to use or interact with a mobile phone ( e.g. those with hearing defects or poor vision)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Call4life
Care givers will be reminded using telephone calls to go vaccine their children
Regular telephone reminders and health information will be sent to help mothers or caregivers of children 0-23 months to remind them to go vaccine their children
Other Names:
  • Call4life

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of zero-dose children aged 0-23 months vaccinated and registered in an immunization registry at the health facility
Time Frame: 6 months
Number of zero-dose children aged 0-23 months vaccinated and registered in an immunization registry at the health facility. The immunization registry which will be used by the health facility to follow up with parents for the vaccination schedules of the children
6 months
Number of care givers to children aged 0-23 months who receive reminder calls from the call for life platform and take their children to the health facility for immunization
Time Frame: 6 months
Number of care givers to children aged 0-23 months who receive reminder calls from the call for life platform and take their children to the health facility for immunization and registration into an immunization registry
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 24, 2025

Primary Completion (Estimated)

November 24, 2025

Study Completion (Estimated)

December 30, 2025

Study Registration Dates

First Submitted

August 15, 2025

First Submitted That Met QC Criteria

August 26, 2025

First Posted (Estimated)

September 4, 2025

Study Record Updates

Last Update Posted (Estimated)

September 4, 2025

Last Update Submitted That Met QC Criteria

August 26, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Call-4-Life
  • Not application (Other Identifier: Cambridge Africa)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

IDP will be shared with researchers involved in the study.

IPD Sharing Time Frame

January 2025 to December 2025

IPD Sharing Access Criteria

Only researchers involved in the study will have access to IPD

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Access to Immunization

Clinical Trials on Telephone calls

3
Subscribe